Evidence map›Paper›PMID 38253074›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[A study of the clinical curative effect of nucleos(t)ide analogues treated to pegylated interferon-α add-on therapy in patients with chronic hepatitis B].

H Liang, C Wang, P F Zhu, Q L Zeng, X B Huang, Y F Pan, Y J Pan, Q Y Hu, X Luo, H Chen and 3 more

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. [Exploring the reasons for liver cancer occurrence still after long-term nucleos(t)ide analogue therapy in patients with chronic hepatitis B].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

H LiangDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
C WangDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
P F ZhuDepartment of Clinical Laboratory, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Q L ZengDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
X B HuangDepartment of Clinical Laboratory, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Y F PanDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Y J PanDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Q Y HuDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
X LuoDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
H ChenDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Z J YuDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
F M LuDepartment of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
J LyuDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
First Affiliated Hospital of Zhengzhou University · CNPeking University · CN

Funding

National Natural Science Foundation of China 81902470, 81970517Provincial and Ministerial Co-construction Medical Science and Technology Project of Henan Province SBGJ202002083Thirteenth Five-Year Major Science and Technology Projects 2017ZX10302201-004-007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B, ChronicInterferon-alphaPolyethylene GlycolsDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensHumansInfantDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensInterferon-alphaPolyethylene GlycolsChronic hepatitis BHepatitis B surface antigen clearanceNucleos(t)ide analoguesPegylated interferonPreviously treatment

Identifiers

PMID38253074
PMCPMC12814140
OpenAlexW4391145133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.